Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Common Shares, No Par Value
- Shares outstanding
- 28,495,649
- Total 13F shares
- 15,958,159
- Share change
- -137,099
- Total reported value
- $39,753,182
- Price per share
- $2.49
- Number of holders
- 48
- Value change
- -$2,942,657
- Number of buys
- 30
- Number of sells
- 26
Quarterly Holders Quick Answers
What is CUSIP 68235C107?
CUSIP 68235C107 identifies OCX - Oncocyte Corporation - Common Shares, No Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 68235C107:
Top shareholders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
|
Company |
28%
|
8,098,267
|
$31,988,000 | — | 31 Mar 2019 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
8.7%
|
2,490,000
|
$9,836,000 | — | 31 Mar 2019 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
4.5%
|
1,288,873
|
$5,091,000 | — | 31 Mar 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.4%
|
1,257,419
|
$4,967,000 | — | 31 Mar 2019 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
3%
|
868,793
|
$3,431,000 | — | 31 Mar 2019 | |
| Manatuck Hill Partners, LLC |
13F
|
Company |
0.85%
|
243,400
|
$961,000 | — | 31 Mar 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.8%
|
228,532
|
$903,000 | — | 31 Mar 2019 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.68%
|
195,000
|
$770,000 | — | 31 Mar 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.66%
|
188,720
|
$744,000 | — | 31 Mar 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.62%
|
177,211
|
$699,000 | — | 31 Mar 2019 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.6%
|
169,635
|
$670,000 | — | 31 Mar 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.48%
|
136,200
|
$538,000 | — | 31 Mar 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.44%
|
125,702
|
$497,000 | — | 31 Mar 2019 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.24%
|
67,300
|
$266,000 | — | 31 Mar 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.2%
|
55,752
|
$220,000 | — | 31 Mar 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.16%
|
45,773
|
$181,000 | — | 31 Mar 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.15%
|
42,172
|
$167,000 | — | 31 Mar 2019 | |
| Spark Investment Management LLC |
13F
|
Company |
0.14%
|
40,300
|
$159,000 | — | 31 Mar 2019 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
32,000
|
$126,000 | — | 31 Mar 2019 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.11%
|
30,006
|
$118,000 | — | 31 Mar 2019 | |
| Destination Wealth Management |
13F
|
Company |
0.1%
|
29,656
|
$117,000 | — | 31 Mar 2019 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.1%
|
28,961
|
$114,000 | — | 31 Mar 2019 | |
| Virtu Financial LLC |
13F
|
Company |
0.1%
|
28,883
|
$114,000 | — | 31 Mar 2019 | |
| PERKINS CAPITAL MANAGEMENT INC |
13F
|
Company |
0.09%
|
25,000
|
$99,000 | — | 31 Mar 2019 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.09%
|
25,000
|
$99,000 | — | 31 Mar 2019 | |
| UBS Group AG |
13F
|
Company |
0.08%
|
22,442
|
$88,000 | — | 31 Mar 2019 | |
| CITIGROUP INC |
13F
|
Company |
0.07%
|
20,767
|
$82,000 | — | 31 Mar 2019 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
20,000
|
$79,000 | — | 31 Mar 2019 | |
| Jump Trading, LLC |
13F
|
Company |
0.07%
|
19,833
|
$78,000 | — | 31 Mar 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
19,473
|
$77,000 | — | 31 Mar 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0.06%
|
18,172
|
$72,000 | — | 31 Mar 2019 | |
| WILLIAMS JONES & ASSOCIATES LLC |
13F
|
Company |
0.05%
|
15,022
|
$59,000 | — | 31 Mar 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.05%
|
13,252
|
$53,000 | — | 31 Mar 2019 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.04%
|
11,963
|
$47,000 | — | 31 Mar 2019 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.04%
|
10,300
|
$41,000 | — | 31 Mar 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
7,803
|
$31,000 | — | 31 Mar 2019 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.02%
|
5,339
|
$21,000 | — | 31 Mar 2019 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.01%
|
3,955
|
$16,000 | — | 31 Mar 2019 | |
| Riggs Asset Managment Co. Inc. |
13F
|
Company |
0.01%
|
3,300
|
$13,000 | — | 31 Mar 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
2,956
|
$12,000 | — | 31 Mar 2019 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0%
|
854
|
$3,000 | — | 31 Mar 2019 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
500
|
$2,000 | — | 31 Mar 2019 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
322
|
$1,000 | — | 31 Mar 2019 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
320
|
$1,000 | — | 31 Mar 2019 | |
| Advisor Group, Inc. |
13F
|
Company |
0%
|
212
|
$1,000 | — | 31 Mar 2019 | |
| CWM, LLC |
13F
|
Company |
0%
|
100
|
$1,000 | — | 31 Mar 2019 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
157
|
$620 | — | 31 Mar 2019 |
Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q2 2019
As of 30 Jun 2019,
Oncocyte Corporation - Common Shares, No Par Value (OCX) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,958,159 shares.
The largest 10 holders included
BROADWOOD CAPITAL INC, EMERALD MUTUAL FUND ADVISERS TRUST, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Maven Securities LTD, Schonfeld Strategic Advisors LLC, Manatuck Hill Partners, LLC, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This page lists
48
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
45
Q2 2019 holders
48
Holder diff
3
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.